Continuity of CVD treatment during the COVID-19 pandemic: evidence from East Java, Indonesia.

ABSTRACT:

Background

In Indonesia, the world's fourth most populous country, cardiovascular diseases (CVDs) are a leading cause of death and disability. Government efforts to reduce the burden of CVD include a community-based prevention and early detection programme, and the provision of medicines to prevent cardiovascular events. Disruptions to medicine supply chains, service provision, and movement during the COVID-19 pandemic potentially threatened the continuity of these efforts. We investigated the distribution and dispensing of common CVD medicines in Malang district, East Java, before the pandemic and early in its course.

Methods

From January to October 2020, we collected monthly data on stock levels, sales or dispensing volumes, and price for five common CVD medicines (amlodip

SUBMITTER: Dewi A 

PROVIDER: S-EPMC10032625 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature